gastrografin challenge vs standard treatment in asbo€¦ · re c u rre n t/ p e rs is te n t b y d...
TRANSCRIPT
![Page 1: Gastrografin Challenge vs Standard Treatment in ASBO€¦ · re c u rre n t/ p e rs is te n t b y d a y 4 - 5 A d v a n c e d ie t S y m p to m re s o lu tio n N o n -o p e ra tiv](https://reader033.vdocument.in/reader033/viewer/2022050301/5f6ab2428a2a2e251e54f962/html5/thumbnails/1.jpg)
Gastrografin Challenge vs Standard Treatment in ASBO
Martin D. Zielinski
EAST Multicenter Trial Proposal
![Page 2: Gastrografin Challenge vs Standard Treatment in ASBO€¦ · re c u rre n t/ p e rs is te n t b y d a y 4 - 5 A d v a n c e d ie t S y m p to m re s o lu tio n N o n -o p e ra tiv](https://reader033.vdocument.in/reader033/viewer/2022050301/5f6ab2428a2a2e251e54f962/html5/thumbnails/2.jpg)
“Never let the sun rise or set on a
small bowel obstruction”
EAST GG Challenge Trial Background
Mucha P. Surg Clin NA 1987; 67(3):597-620
![Page 3: Gastrografin Challenge vs Standard Treatment in ASBO€¦ · re c u rre n t/ p e rs is te n t b y d a y 4 - 5 A d v a n c e d ie t S y m p to m re s o lu tio n N o n -o p e ra tiv](https://reader033.vdocument.in/reader033/viewer/2022050301/5f6ab2428a2a2e251e54f962/html5/thumbnails/3.jpg)
EAST GG Challenge Trial Background
• Non-op management
• Greater resection risk
if > 24 hours
• Electrolyte and fluid
imbalances
Bickell et al. J Am Coll Surg 2005; 201:847-854
![Page 4: Gastrografin Challenge vs Standard Treatment in ASBO€¦ · re c u rre n t/ p e rs is te n t b y d a y 4 - 5 A d v a n c e d ie t S y m p to m re s o lu tio n N o n -o p e ra tiv](https://reader033.vdocument.in/reader033/viewer/2022050301/5f6ab2428a2a2e251e54f962/html5/thumbnails/4.jpg)
• > 50% of strangulation
obstructions are
misdiagnosed
• Which patients should
undergo operative
treatment?
EAST GG Challenge Trial Background
Sarr et al. AJS 1983; 145(1):176-182.
![Page 5: Gastrografin Challenge vs Standard Treatment in ASBO€¦ · re c u rre n t/ p e rs is te n t b y d a y 4 - 5 A d v a n c e d ie t S y m p to m re s o lu tio n N o n -o p e ra tiv](https://reader033.vdocument.in/reader033/viewer/2022050301/5f6ab2428a2a2e251e54f962/html5/thumbnails/5.jpg)
EAST GG Challenge Trial Optimal Approach
• 1 – provide immediate exploration for
strangulation obstructions
• 2 – facilitate early recognition of
patients who will not resolve without
operative intervention
• 3 – minimize unnecessary operations
![Page 6: Gastrografin Challenge vs Standard Treatment in ASBO€¦ · re c u rre n t/ p e rs is te n t b y d a y 4 - 5 A d v a n c e d ie t S y m p to m re s o lu tio n N o n -o p e ra tiv](https://reader033.vdocument.in/reader033/viewer/2022050301/5f6ab2428a2a2e251e54f962/html5/thumbnails/6.jpg)
EAST GG Challenge Trial GG Challenge
• Gastrografin
• Hyperosmotic
oral contrast agent
• Diagnostic Rx
• Therapeutic Rx
![Page 7: Gastrografin Challenge vs Standard Treatment in ASBO€¦ · re c u rre n t/ p e rs is te n t b y d a y 4 - 5 A d v a n c e d ie t S y m p to m re s o lu tio n N o n -o p e ra tiv](https://reader033.vdocument.in/reader033/viewer/2022050301/5f6ab2428a2a2e251e54f962/html5/thumbnails/7.jpg)
• 55 GG Challenge vs 72 historic controls
• 25% vs 42% surgical exploration
• 13% vs 31% complications
• Equal LOS, strangulation, mortality
EAST GG Challenge Trial GG Challenge vs Standard
![Page 8: Gastrografin Challenge vs Standard Treatment in ASBO€¦ · re c u rre n t/ p e rs is te n t b y d a y 4 - 5 A d v a n c e d ie t S y m p to m re s o lu tio n N o n -o p e ra tiv](https://reader033.vdocument.in/reader033/viewer/2022050301/5f6ab2428a2a2e251e54f962/html5/thumbnails/8.jpg)
EAST GG Challenge Trial GG Meta-analysis
• Diagnostic effects
• 7 RCTs
• 99% PPV, 90% NPV
• 8 hour X-ray ideal
• Therapeutic effects
• 9 RCTs
• Exploration 21% vs 30%; p = .007
• 1.9 day LOS improvement
Branco, BJS 2010
![Page 9: Gastrografin Challenge vs Standard Treatment in ASBO€¦ · re c u rre n t/ p e rs is te n t b y d a y 4 - 5 A d v a n c e d ie t S y m p to m re s o lu tio n N o n -o p e ra tiv](https://reader033.vdocument.in/reader033/viewer/2022050301/5f6ab2428a2a2e251e54f962/html5/thumbnails/9.jpg)
Mixed results among RCTs
• Inconsistent SBO definition
• Lack of blinding
• Non-controlled studies
• Conflicting inclusion / exclusion
• Variable contrast media
• Variable doses
• 4 – 72 hour X-ray
• Variable strangulation reporting
SBO Exploration Prediction Gastrografin Meta-analysis
![Page 10: Gastrografin Challenge vs Standard Treatment in ASBO€¦ · re c u rre n t/ p e rs is te n t b y d a y 4 - 5 A d v a n c e d ie t S y m p to m re s o lu tio n N o n -o p e ra tiv](https://reader033.vdocument.in/reader033/viewer/2022050301/5f6ab2428a2a2e251e54f962/html5/thumbnails/10.jpg)
• Prospective, observational trial
• Institutional standardization
• GG Challenge vs.
• “Standard Management”
• 200 patients total – 100 per arm
• Heavy data collection and protocol compliance
SBO Exploration Prediction Proposal
![Page 11: Gastrografin Challenge vs Standard Treatment in ASBO€¦ · re c u rre n t/ p e rs is te n t b y d a y 4 - 5 A d v a n c e d ie t S y m p to m re s o lu tio n N o n -o p e ra tiv](https://reader033.vdocument.in/reader033/viewer/2022050301/5f6ab2428a2a2e251e54f962/html5/thumbnails/11.jpg)
SBO Exploration Prediction Proposal
• Symptoms consistent with a strangulation obstruction
• Incarcerated external hernia
• Portal-venous gas
• Pneumatosis intestinalis
• Closed loop SBO (two independent transition points)
• Internal hernia
• Small bowel volvulus
• Peritonitis on physical exam
• Hypotension (systolic blood pressure < 90 mm Hg)
• Recent abdominal procedure
![Page 12: Gastrografin Challenge vs Standard Treatment in ASBO€¦ · re c u rre n t/ p e rs is te n t b y d a y 4 - 5 A d v a n c e d ie t S y m p to m re s o lu tio n N o n -o p e ra tiv](https://reader033.vdocument.in/reader033/viewer/2022050301/5f6ab2428a2a2e251e54f962/html5/thumbnails/12.jpg)
SBO Exploration Prediction Proposal
• Primary aim
• 1. To determine, the GG Challenge’s ability to predict resolution of adhesive SBO.
• Outcome - Accuracy of predicting the need for operative exploration (i.e. PPV/NPV)
• Hypothesis – GG will improve the NPV/ PPV for predicting exploration in ASBO
![Page 13: Gastrografin Challenge vs Standard Treatment in ASBO€¦ · re c u rre n t/ p e rs is te n t b y d a y 4 - 5 A d v a n c e d ie t S y m p to m re s o lu tio n N o n -o p e ra tiv](https://reader033.vdocument.in/reader033/viewer/2022050301/5f6ab2428a2a2e251e54f962/html5/thumbnails/13.jpg)
SBO Exploration Prediction Proposal
• Secondary aims:
• 1. To determine the GG Challenge’s ability to treat adhesive SBO.
• Outcome – exploration rate
• Hypothesis – GG will reduce the rate of explorations in ASBO.
• 2. To validate the AAST SBO anatomic score
• Outcome - mortality prediction (AUROC)
• The AUROC of the AAST anatomic score will be greater than 0.80
![Page 14: Gastrografin Challenge vs Standard Treatment in ASBO€¦ · re c u rre n t/ p e rs is te n t b y d a y 4 - 5 A d v a n c e d ie t S y m p to m re s o lu tio n N o n -o p e ra tiv](https://reader033.vdocument.in/reader033/viewer/2022050301/5f6ab2428a2a2e251e54f962/html5/thumbnails/14.jpg)
Patient arrives with signs and
Symptoms of SBO
Page 1
Adhesive Small Bowel Obstruction (SBO) Protocol – Gastrografin Challenge Institutions
Signs of
strangulation
Symptoms
increasing or
recurrent/
persistent by day
3-5
Advance diet
Symptom
resolution
Non-operative trial
Presence of 3 risk factors:
· Obstipation
· Mesenteric edema
· Lack of small bowel feces
sign
Dismiss
Prior abdominal
proceedure
Gastrografin Challenge
Bowel movement
OR contrast
within colon by 8
hours
NO, order CT
YES
NO
NO
YES
NO
YES
YES
YESOperative
exploration
Consider
Operative
exploration
Operative
exploration
![Page 15: Gastrografin Challenge vs Standard Treatment in ASBO€¦ · re c u rre n t/ p e rs is te n t b y d a y 4 - 5 A d v a n c e d ie t S y m p to m re s o lu tio n N o n -o p e ra tiv](https://reader033.vdocument.in/reader033/viewer/2022050301/5f6ab2428a2a2e251e54f962/html5/thumbnails/15.jpg)
Patient arrives with signs and
Symptoms of SBO
Page 1
Adhesive Small Bowel Obstruction (SBO) Protocol – Non-Gastrografin Challenge Institutions
Signs of ischemia
Symptoms
increasing or
recurrent/
persistent by day
4-5
Advance diet
Symptom
resolution
Non-operative trial
Presence of 3 risk factors:
· Obstipation
· Mesenteric edema
· Lack of small bowel feces
sign
Dismiss
Prior abdominal
proceedure
NO, order CT
YES
NO
NO
YES
YES
YES
YESOperative
exploration
Operative
exploration
![Page 19: Gastrografin Challenge vs Standard Treatment in ASBO€¦ · re c u rre n t/ p e rs is te n t b y d a y 4 - 5 A d v a n c e d ie t S y m p to m re s o lu tio n N o n -o p e ra tiv](https://reader033.vdocument.in/reader033/viewer/2022050301/5f6ab2428a2a2e251e54f962/html5/thumbnails/19.jpg)
• Feb 15 - participating centers identified
• March 15 - IRBs approved
• April 1, 2015 - Study initiation
• January 1, 2016 - Study completion
• Feb 2016 - Data analysis
• EAST submission July 1, 2016
SBO Exploration Prediction Timeline